NIH-funded research P01 program project

Optimizing life for throat (oropharyngeal) cancer survivors

Official title: OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORship

Funded at University of Tx Md Anderson Can Ctr · NIH-11180353 · Data updated 2026-11-12

This project aims to find better ways to prevent and treat long-term jaw, mouth, and swallowing problems in adults who have survived oropharyngeal (throat) cancer.

More Survivorship research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2029
Funding year2025
Award (this year)$2,341,478
NIH project number5P01CA285249-02
Project IDNIH-11180353 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+) who have been treated for oropharyngeal (throat) cancer—especially HPV-related cases—or who are living with or at risk for late treatment-related problems like osteoradionecrosis or chronic dysphagia.

Less likely to help

People with cancers outside the oropharynx, children, or patients still in initial curative treatment are unlikely to benefit directly from this survivorship-focused program.

What this research studies

You would be part of a program that follows adult survivors of oropharyngeal cancer to understand and reduce late side effects such as mandibular bone damage and delayed swallowing problems. The team combines regular clinical follow-up, imaging, and collection of patient samples with detailed treatment records to link symptoms to prior surgery, radiation, or therapies. They will pilot and refine clinical approaches including changes to radiation/surgical practice and rehabilitation to lower long-term harm. Laboratory and translational work at collaborating sites will help explain biological causes and suggest new ways to protect tissue and restore function.

Why it matters

Potential benefit: If successful, the work could lower the risk of long-term jaw and swallowing complications and improve quality of life and return-to-work outcomes for survivors.

How similar studies have gone: Prior attempts to reduce treatment intensity have sometimes worsened outcomes and advances like transoral surgery or conformal radiotherapy still leave substantial late toxicities, so this program targets these persistent survivorship problems.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Hutcheson, Katherine Arnold — University of Tx Md Anderson Can Ctr
  • Study coordinator: Hutcheson, Katherine Arnold

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.